These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 15492787
1. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma. Tsukinoki K, Yasuda M, Mori Y, Asano S, Naito H, Ota Y, Osamura RY, Watanabe Y. Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787 [Abstract] [Full Text] [Related]
2. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. Cancer Res; 1997 Aug 01; 57(15):3305-13. PubMed ID: 9242465 [Abstract] [Full Text] [Related]
3. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma. Xie LQ, Bian LJ, Li Z, Li Y, Li ZX, Li B. Ann Surg Oncol; 2010 Jul 01; 17(7):1927-36. PubMed ID: 20131016 [Abstract] [Full Text] [Related]
4. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH, Kim J, Kahng H, Choi EC. Ann Surg Oncol; 2007 May 01; 14(5):1565-74. PubMed ID: 17294073 [Abstract] [Full Text] [Related]
5. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. Chen YS, Wang JT, Chang YF, Liu BY, Wang YP, Sun A, Chiang CP. J Oral Pathol Med; 2004 Apr 01; 33(4):209-17. PubMed ID: 15061708 [Abstract] [Full Text] [Related]
6. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH. Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653 [Abstract] [Full Text] [Related]
7. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J. Vet Pathol; 2009 Sep 01; 46(5):869-77. PubMed ID: 19429984 [Abstract] [Full Text] [Related]
8. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Nakashiro K, Hayashi Y, Oyasu R. Oncol Rep; 2003 Sep 01; 10(5):1149-53. PubMed ID: 12883672 [Abstract] [Full Text] [Related]
9. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. Varnholt H, Asayama Y, Aishima S, Taguchi K, Sugimachi K, Tsuneyoshi M. Oncol Rep; 2002 Sep 01; 9(1):35-41. PubMed ID: 11748452 [Abstract] [Full Text] [Related]
10. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met. Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M. Int J Oncol; 2008 Oct 01; 33(4):697-703. PubMed ID: 18813782 [Abstract] [Full Text] [Related]
14. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland. Ikari T, Hiraki A, Seki K, Sugiura T, Matsumoto K, Shirasuna K. Dev Dyn; 2003 Oct 01; 228(2):173-84. PubMed ID: 14517989 [Abstract] [Full Text] [Related]
15. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Schwarz S, Ettl T, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Oral Oncol; 2008 Jun 01; 44(6):563-70. PubMed ID: 17936671 [Abstract] [Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A. BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120 [Abstract] [Full Text] [Related]